Briacell Therapeutics Corp BCTXW

Primary Symbol: T.BCT Alternate Symbol(s): BCTX

Healthcare Biotechnology

BriaCell Therapeutics Corp. is a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care. Bria-IMT, its Phase 3 lead candidate, is a patented, off-the-shelf, cell-based, targeted immunotherapy that activates the patient’s immune system to specifically kill cancer cells without harming other cells. The Company is advancing its Bria-IMT targeted immunotherapy in combination with an immune check point inhibitor (Retifanlimab) in a pivotal Phase 3 study in metastatic breast cancer. It is also developing personalized off-the-shelf immunotherapies, Bria-OTS and Bria-OTS+, which provides a platform technology to develop personalized off-the-shelf immunotherapies for numerous types of cancer, and a soluble CD80 protein therapeutic which act both as a stimulator of the immune system, as well as an immune checkpoint inhibitor. Its pipeline also includes Bria-IMT + CPI, Bria-BRES/BRES+, Bria-PROS+, Bria-LUNG+ and Bria-MEL+.

TSX:BCT - Post by User

Briacell Therapeutics Corp > thanks for those cheap shares

<< Previous

Bullboard Posts

Next >>

Comment by Iseneschalon Sep 19, 2024 2:58pm

53 Views

Post# 36231601

RE:RE:thanks for those cheap shares

I am now going to call you a Spin Doctor......sounds like your playing this for pennies after losing at least a $1 per share when the P.O was announced

And you call a 5 cent gain "A squeeze" ?

I can read you like a book Buddy.

Your eyes are brown

<< Previous

Bullboard Posts

Next >>

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)